Cara Therapeutics | CARA - Beneficio Operativo

Precio De Mercado
4.18
Cambio Diario
-0.03 -0.71%
Mensual
41.22%
Anual
-83.68%
Q2 Expectativa
3.07




Beneficio Operativo Cambio Fecha
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Assertio Holdings USD -3.05M 569K 2024-09
Cara Therapeutics USD -5.94M 3.55M 2025-09
Cassava Sciences USD -13.55M 1.69M 2025-12
Chugai Pharma JPY 158.77B 10.24B 2026-03
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD 56.04M 63.93M 2025-12
CSL USD 2.64B 1.97B 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
J&J USD 6.62B 1.03B 2026-03
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Pacira USD 4.62M 1.43M 2026-03
Pfizer USD 4.99B 340M 2026-03
RedHill Biopharma USD -4.22M 1.8M 2024-06
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
Vanda Pharmaceuticals USD -40.66M 29.66M 2024-12